全文获取类型
收费全文 | 364086篇 |
免费 | 4092篇 |
国内免费 | 1049篇 |
专业分类
化学 | 201447篇 |
晶体学 | 6403篇 |
力学 | 14942篇 |
综合类 | 15篇 |
数学 | 36150篇 |
物理学 | 110270篇 |
出版年
2019年 | 2928篇 |
2018年 | 3330篇 |
2017年 | 3401篇 |
2016年 | 5465篇 |
2015年 | 3643篇 |
2014年 | 5625篇 |
2013年 | 15746篇 |
2012年 | 10988篇 |
2011年 | 13572篇 |
2010年 | 9381篇 |
2009年 | 9286篇 |
2008年 | 12162篇 |
2007年 | 12168篇 |
2006年 | 11563篇 |
2005年 | 10473篇 |
2004年 | 9558篇 |
2003年 | 8681篇 |
2002年 | 8373篇 |
2001年 | 10452篇 |
2000年 | 7997篇 |
1999年 | 6262篇 |
1998年 | 5015篇 |
1997年 | 4962篇 |
1996年 | 4832篇 |
1995年 | 4508篇 |
1994年 | 4323篇 |
1993年 | 4081篇 |
1992年 | 5065篇 |
1991年 | 4888篇 |
1990年 | 4758篇 |
1989年 | 4783篇 |
1988年 | 4756篇 |
1987年 | 4798篇 |
1986年 | 4525篇 |
1985年 | 5971篇 |
1984年 | 6004篇 |
1983年 | 4852篇 |
1982年 | 5129篇 |
1981年 | 5158篇 |
1980年 | 4858篇 |
1979年 | 5257篇 |
1978年 | 5490篇 |
1977年 | 5454篇 |
1976年 | 5233篇 |
1975年 | 4870篇 |
1974年 | 4803篇 |
1973年 | 4787篇 |
1972年 | 3225篇 |
1968年 | 3383篇 |
1967年 | 3459篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Development and validation of a reversed‐phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva 下载免费PDF全文
Elias Begas Evangelos Kouvaras Andreas K. Tsakalof Maria Bounitsi Eftihia Konstadinos Asprodini 《Biomedical chromatography : BMC》2015,29(11):1657-1663
CYP1A2 is important for metabolizing various clinically used drugs. Phenotyping of CYP1A2 may prove helpful for drug individualization therapy. Several HPLC methods have been developed for quantification of caffeine metabolites in plasma and urine. Aim of the present study was to develop a valid and simple HPLC method for evaluating CYP1A2 activity during exposure in xenobiotics by the use of human saliva. Caffeine and paraxanthine were isolated from saliva by liquid‐liquid extraction (chlorophorm/isopropanol 85/15v/v). Extracts were analyzed by reversed‐phase HPLC on a C18 column with mobile phase 0.1% acetic acid/methanol/acetonitrile (80/20/2 v/v) and detected at 273nm. Caffeine and paraxanthine elution times were <13min with no interferences from impurities or caffeine metabolites. Detector response was linear (0.10–8.00µg/ml, R2>0.99), recovery was >93% and bias <4.47%. Intra‐ and inter‐day precision was <5.14% (n=6). The limit of quantitation was 0.10µg/ml and the limit of detection was 0.018±0.002µg/mL for paraxanthine and 0.032±0.002µg/ml for caffeine. Paraxanthine/caffeine ratio of 34 healthy volunteers was significantly higher in smokers (p<0.001). Saliva paraxanthine/caffeine ratios and urine metabolite ratios were highly correlated (r=0.85, p<0.001). The method can be used for the monitoring of CYP1A2 activity in clinical practice and in studies relevant to exposure to environmental and pharmacological xenobiotics. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
82.
Ivanov K. A. Gubaidullin A. R. Morozov K. M. Sasin M. E. Kaliteevskii M. A. 《Optics and Spectroscopy》2019,126(6):787-787
Optics and Spectroscopy - 10.1134/S0030400X17050095 相似文献
83.
K. Volkan
zdokur 《Electroanalysis》2020,32(3):489-495
Copper oxide decorated multi‐walled carbon nanotube (MWCNT) modified glassy carbon electrode (GCE) was prepared for determination of isoniazid (INZ) in various matrices. The electrochemical behavior of INZ was tested with the aid of Cyclic Voltammetry (CV) and quantitative experiments were performed by using Linear Sweep Voltammetry (LSV). Morphological and structural characterization of the modified electrode was performed by utilizing Scanning Electron Microscopy (SEM), X‐Ray Photoelectron Spectroscopy (XPS) while electrochemical characterization was performed by using CV and Electrochemical Impedance spectroscopy (EIS). The proposed sensor exhibited well defined anodic peak at 0.30 V for INZ at pH 6.0 medium. Under the optimum conditions, a linear relation between INZ concentration and peak current was observed in the range of 2.0×10?7 to 5.0×10?5 M. Limit of detection was calculated as 1.0×10?8 M and repeatability and accuracy was found as 5.60 % and 91.0 % for 5.0 10?7 M INZ by using 3 successive measurement, respectively. Then, the analytic performance of the electrode developed was tested by analyzing commercial tablets, artificial human serum and urine samples. The results indicated that satisfactory recoveries was observed for all issue. 相似文献
84.
85.
86.
87.
Kinetics and Catalysis - Boron and barium were employed as dopants for the VMgO system. The catalysts were characterized by ICP-OES, BET, IR, powder XRD, EDX, TPR-H2, TPD-NH3, XPS, and 51V MAS NMR.... 相似文献
88.
Chris H. Hill Agnete H. Viuff Samantha J. Spratley Stéphane Salamone Stig H. Christensen Randy J. Read Nigel W. Moriarty Henrik H. Jensen Janet E. Deane 《Chemical science》2015,6(5):3075-3086
Krabbe disease is a devastating neurodegenerative disorder characterized by rapid demyelination of nerve fibers. This disease is caused by defects in the lysosomal enzyme β-galactocerebrosidase (GALC), which hydrolyzes the terminal galactose from glycosphingolipids. These lipids are essential components of eukaryotic cell membranes: substrates of GALC include galactocerebroside, the primary lipid component of myelin, and psychosine, a cytotoxic metabolite. Mutations of GALC that cause misfolding of the protein may be responsive to pharmacological chaperone therapy (PCT), whereby small molecules are used to stabilize these mutant proteins, thus correcting trafficking defects and increasing residual catabolic activity in cells. Here we describe a new approach for the synthesis of galacto-configured azasugars and the characterization of their interaction with GALC using biophysical, biochemical and crystallographic methods. We identify that the global stabilization of GALC conferred by azasugar derivatives, measured by fluorescence-based thermal shift assays, is directly related to their binding affinity, measured by enzyme inhibition. X-ray crystal structures of these molecules bound in the GALC active site reveal which residues participate in stabilizing interactions, show how potency is achieved and illustrate the penalties of aza/iminosugar ring distortion. The structure–activity relationships described here identify the key physical properties required of pharmacological chaperones for Krabbe disease and highlight the potential of azasugars as stabilizing agents for future enzyme replacement therapies. This work lays the foundation for new drug-based treatments of Krabbe disease. 相似文献
89.
90.